{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T05:42:15Z","timestamp":1774935735243,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP 21K08515"],"award-info":[{"award-number":["JP 21K08515"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJPR22R2"],"award-info":[{"award-number":["JPMJPR22R2"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s10096-024-04973-x","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T15:53:40Z","timestamp":1730822020000},"page":"45-51","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Optimal incubation duration of liquid cultures for assessing culture negative conversion in patients with Mycobacterium avium complex and Mycobacterium abscessus pulmonary diseases"],"prefix":"10.1007","volume":"44","author":[{"given":"Yoshifumi","family":"Uwamino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Kamoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rika","family":"Inose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho","family":"Namkoong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyasu","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"4973_CR1","first-page":"1","volume":"54","author":"PA Jensen","year":"2005","unstructured":"Jensen PA, Lambert LA, Iademarco MF, Ridzon R (2005) Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 54:1\u2013141","journal-title":"MMWR Recomm Rep"},{"key":"4973_CR2","doi-asserted-by":"publisher","first-page":"2000535","DOI":"10.1183\/13993003.00535-2020","volume":"56","author":"CL Daley","year":"2020","unstructured":"Daley CL, Iaccarino JM, Lange C et al (2020) Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline. Eur Respir J 56:2000535. https:\/\/doi.org\/10.1183\/13993003.00535-2020","journal-title":"Eur Respir J"},{"key":"4973_CR3","doi-asserted-by":"publisher","first-page":"1800170","DOI":"10.1183\/13993003.00170-2018","volume":"51","author":"J van Ingen","year":"2018","unstructured":"van Ingen J, Aksamit T, Andrejak C et al (2018) Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement. Eur Respir J 51:1800170. https:\/\/doi.org\/10.1183\/13993003.00170-2018","journal-title":"Eur Respir J"},{"key":"4973_CR4","unstructured":"CLSI (2018) Laboratory detection and identification of Mycobacteria, 2nd ed. CLSI standard M48. Clinical and Laboratory Standard Institute, Wayne, PA"},{"key":"4973_CR5","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1128\/jcm.18.2.384-388.1983","volume":"18","author":"MA Morgan","year":"1983","unstructured":"Morgan MA, Horstmeier CD, DeYoung DR, Roberts GD (1983) Comparison of a radiometric method (BACTEC) and conventional culture media for recovery of mycobacteria from smear-negative specimens. J Clin Microbiol 18:384\u2013388. https:\/\/doi.org\/10.1128\/jcm.18.2.384-388.1983","journal-title":"J Clin Microbiol"},{"key":"4973_CR6","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1128\/JCM.01225-12","volume":"50","author":"FC Tyrrell","year":"2012","unstructured":"Tyrrell FC, Budnick GE, Elliott T et al (2012) Probability of negative mycobacterium tuberculosis complex cultures based on time to detection of positive cultures: a multicenter evaluation of commercial-broth-based culture systems. J Clin Microbiol 50:3275\u20133282. https:\/\/doi.org\/10.1128\/JCM.01225-12","journal-title":"J Clin Microbiol"},{"key":"4973_CR7","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.1038\/srep04236","volume":"4","author":"R Ghodbane","year":"2014","unstructured":"Ghodbane R, Raoult D, Drancourt M (2014) Dramatic reduction of culture time of Mycobacterium tuberculosis. Sci Rep 4:4236. https:\/\/doi.org\/10.1038\/srep04236","journal-title":"Sci Rep"},{"key":"4973_CR8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1513\/AnnalsATS.201804-236OC","volume":"17","author":"KL Winthrop","year":"2020","unstructured":"Winthrop KL, Marras TK, Adjemian J, Zhang H, Wang P, Zhang Q (2020) Incidence and prevalence of nontuberculous mycobacterial lung disease in a large U.S. managed care health plan, 2008\u20132015. Ann Am Thorac Soc 17:178\u2013185. https:\/\/doi.org\/10.1513\/AnnalsATS.201804-236OC","journal-title":"Ann Am Thorac Soc"},{"key":"4973_CR9","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.3201\/eid2206.151086","volume":"22","author":"H Namkoong","year":"2016","unstructured":"Namkoong H, Kurashima A, Morimoto K et al (2016) Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan. Emerg Infect Dis 22:1116\u20131117. https:\/\/doi.org\/10.3201\/eid2206.151086","journal-title":"Emerg Infect Dis"},{"key":"4973_CR10","unstructured":"Nippon Becton Dickenson Company Ltd (2023) MGIT culture medium Package Insert, https:\/\/www.info.pmda.go.jp\/downfiles\/ivd\/PDF\/530513_21300AMY00496000_A_02_03.pdf. Accessed 29 Aug 2024. in Japanese"},{"key":"4973_CR11","unstructured":"Committee for the Evaluation of Mycobacterial Testing Methods Japanese Soceity for Tuberculosis (2007) Guidelines for Tuberculosis Testing 2007. Japan Anti-Tuberculosis Association. Published 10 Aug 2007. In Japanese"},{"key":"4973_CR12","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1513\/AnnalsATS.202107-765OC","volume":"19","author":"BD Edwards","year":"2022","unstructured":"Edwards BD, Brode SK, Mehrabi M, Marras TK (2022) Time to positive culture detection predicts Mycobacterium avium pulmonary disease severity and treatment initiation. Ann Am Thorac Soc 19:925\u2013932. https:\/\/doi.org\/10.1513\/AnnalsATS.202107-765OC","journal-title":"Ann Am Thorac Soc"},{"key":"4973_CR13","doi-asserted-by":"publisher","first-page":"e0179420","DOI":"10.1128\/AAC.01794-20","volume":"65","author":"AD Gewitz","year":"2021","unstructured":"Gewitz AD, Solans BP, Mac Kenzie WR et al (2021) Longitudinal model-based biomarker analysis of exposure-response relationships in adults with pulmonary tuberculosis. Antimicrob Agents Chemother 65:e0179420. https:\/\/doi.org\/10.1128\/AAC.01794-20","journal-title":"Antimicrob Agents Chemother"},{"key":"4973_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1186\/s12879-021-06220-6","volume":"21","author":"J Namugenyi","year":"2021","unstructured":"Namugenyi J, Musaazi J, Katamba A et al (2021) Baseline xpert MTB\/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study. BMC Infect Dis 21:513. https:\/\/doi.org\/10.1186\/s12879-021-06220-6","journal-title":"BMC Infect Dis"},{"key":"4973_CR15","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1128\/JCM.02283-12","volume":"50","author":"GE Pfyffer","year":"2012","unstructured":"Pfyffer GE, Wittwer F (2012) Incubation time of mycobacterial cultures: how long is long enough to issue a final negative report to the clinician? J Clin Microbiol 50:4188\u20134189. https:\/\/doi.org\/10.1128\/JCM.02283-12","journal-title":"J Clin Microbiol"},{"key":"4973_CR16","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1164\/rccm.201807-1318OC","volume":"198","author":"DE Griffith","year":"2018","unstructured":"Griffith DE, Eagle G, Thomson R et al (2018) Amikacin Liposome inhalation suspension for treatment-refractory lung disease caused by Mycobacterium avium complex (CONVERT). A prospective, open-label, randomized study. Am J Respir Crit Care Med 198:1559\u20131569. https:\/\/doi.org\/10.1164\/rccm.201807-1318OC","journal-title":"Am J Respir Crit Care Med"},{"key":"4973_CR17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12879-022-07250-4","volume":"22","author":"CM Mingora","year":"2022","unstructured":"Mingora CM, Garcia BA, Mange KC et al (2022) Time-to-positivity of Mycobacterium avium complex in broth culture associates with culture conversion. BMC Infect Dis 22:246. https:\/\/doi.org\/10.1186\/s12879-022-07250-4","journal-title":"BMC Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04973-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-024-04973-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04973-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T10:46:43Z","timestamp":1737024403000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-024-04973-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["4973"],"URL":"https:\/\/doi.org\/10.1007\/s10096-024-04973-x","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"assertion":[{"value":"21 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors used Chat GPT 3.5 to improve the quality of the English. After using this tool, the authors reviewed and edited the content as needed, and take full responsibility for the content of the publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}